University of Florida Received £500,000 Grant From Duchenne UK to Overcome Immunity Challenges in Gene Therapy
Duchenne UK has partnered with one of the world’s leading gene therapy teams focusing on AAV immunology. Drs. Manuela Corti and Barry Byrne at the Powell Gene Therapy Center, University of Florida, will try to temporarily modify the immune system so that anybody can be treated with gene therapy, and, if necessary, can receive repeat […]
Adapting Neurological Care Amid COVID-19
As the ongoing battle against the spread of COVID-19 continues, the medical community is learning more about the disease and at-risk populations by the day. Many symptoms and comorbidities associated with neurologic disorders place patients, especially those in the neuromuscular disease community, within those high-risk categories established by the Centers for Disease Control and Prevention […]
UF Health Researchers Working to Develop COVID-19 Vaccine Using Gene Therapy Technique
A team of University of Florida Health researchers is using an established gene therapy technique to quickly develop a COVID-19 vaccine that could be tested in humans later this year. The technique uses a harmless virus to help fight a harmful virus. In this case, the harmless virus is used to package and deliver a gene from […]
Dr. Barry Byrne Featured in Denison Magazine
Barry J. Byrne, M.D., Ph.D., director of the University of Florida Powell Gene Therapy Center, a professor in Pediatrics and Molecular Genetics & Microbiology, and the associate chair in Pediatrics at the University of Florida, is studying a variety of rare diseases with specific attention to developing therapies for inherited muscle disease. His development of the Powell Gene […]